Why the study?
Autoimmune pericarditis is a unique phenotype of pericarditis with a varied clinical spectrum and distinct pathophysiology, but data regarding it remain scarce.
Answers are grounded in this paper and cite their sources.
This review highlights the distinct pathophysiology of autoimmune pericarditis and suggests that targeted therapies like IL-1 inhibition may be beneficial for specific phenotypes.
PURPOSE OF REVIEW: To provide an overview of the diagnosis and updated therapeutic approach to autoimmune pericarditis. RECENT FINDINGS: Subtypes of autoimmune pericarditis may benefit from IL-1 inhibition and future phenotyping based on clinical presentation, biomarkers, and imaging may aid in guiding future therapeutic approaches. Autoimmune pericarditis is a unique phenotype of pericarditis for which there is scarce data. The clinical spectrum of pericardial involvement associated with autoimmune disorders varies in acuity, recurrence, severity, and symptomatic presentation. There is a pathophysiologic distinction that separates autoimmune and autoinflammatory pericarditis from other pericarditis presentations. This review explores the state of the art in diagnosis and therapeutic management.
No takes yet. Share an insight, caveat, or question.
Wassif et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: